GC Green Cross Medical Foundation and Infeco Sign MOU for Introduction of Automated Pathology Laboratory Systems

Pioneering Korea's First Automated Pathology Slide Preparation Process

GC Green Cross Medical Foundation (GC Labs) announced on October 28 that it has signed a memorandum of understanding (MOU) with Swiss company Infeco for the introduction of automated systems for pathology laboratories.

Ricardo Triunfo, CEO of Infeco (left), and Lee Sanggon, President of GC Green Cross Medical Foundation (right), are posing for a commemorative photo at the signing ceremony held on the 25th at the GC Green Cross Medical Foundation IT Center in Yongin, Gyeonggi Province. GC Green Cross Medical Foundation

The signing ceremony, held on October 25 at the GC Green Cross Medical Foundation IT Center in Yongin, Gyeonggi Province, was attended by Lee Sanggon, President of GC Green Cross Medical Foundation; Heo Jooyoung, Director of Pathology; Ahn Sunhyun, Medical Specialist; Choi Seungkwon, Head of Management; as well as Ricardo Triunfo, CEO of Infeco, and Marco Bellini, Chief of Pathology, along with other representatives from both organizations.

This agreement represents a strategic collaboration aimed at dramatically advancing the level of automation in the field of pathology and achieving internationally recognized standards of diagnostic quality and efficiency.

Through this partnership, the two companies will work together to introduce and optimize automation solutions across the entire pathology testing process. In particular, the goal is to achieve full automation and traceability in the processes of slide preparation, staining, and storage, with plans to explore integration with artificial intelligence (AI)-based pathology imaging interpretation systems in the future.

To date, the process of preparing slides from tissue samples in pathology laboratories worldwide has been performed mostly manually, with only a few institutions in Europe having adopted automated systems at an early and limited stage.

GC Green Cross Medical Foundation plans to create a turning point in the field by becoming the first in Korea to introduce an automated system for pathology slide preparation, significantly enhancing the efficiency and reproducibility of pathology diagnostics.

Infeco is a global company that supplies automation solutions to major clinical laboratories in over 70 countries and is recognized for its advanced technology in the standardization of testing processes and automation of quality control.

President Lee stated, "This agreement is a symbolic project that leads the paradigm shift in pathology automation. With world-class automation technology, we will realize standardization in the pathology testing process and simultaneously improve both the efficiency of laboratory work and the accuracy of diagnoses."

CEO Ricardo Triunfo commented, "GC Green Cross Medical Foundation is one of the most innovative diagnostic institutions in the world and a leader in adopting new technologies. This collaboration will establish a new standard for pathology laboratory automation."

Meanwhile, starting with this agreement, the two companies plan to gradually implement the pathology laboratory automation project through joint technical reviews, design, and step-by-step collaboration in commissioning.

This content was produced with the assistance of AI translation services.